KB

Kristin Baker Spohn

Investor, Builder

San Francisco Bay Area

VC
Investor
Angel

Invests in

Stages:

Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $20,000,000.00

  • Target Investment:

    $13,000,000.00

Skills

Corporate Development
Valuation
Strategy
Strategic Negotiations
Mergers
Due Diligence
Investments
Finance
Financial Services
Market Research
Strategic Planning
Mergers & Acquisitions
Investment Banking
Healthcare Information Technology
Healthcare
SaaS
Strategic Partnerships
Leadership
Venture Capital
Analysis

Education

Investments

Archy

Pre Seed

Total Funding: $10M

Power Life Science

Seed

Total Funding: $19M

Wheel

Series A

Total Funding: $220M

Little Otter

Series A

Total Funding: $26M

Cradlewise Inc.

Seed

Total Funding: $7M

Marley Medical

Seed

Total Funding: $9M

Waitwhile

Series A

Total Funding: $12M

Curve Health

Seed

Total Funding: $18M

Work Experience

BAM Elevate

2023

  • General Partner

    2023

Stanford University Graduate School of Business

2022

  • Lecturer in Management

    2022

    Teaching team for Startup Garage.

CRV

2019 - 2023

  • General Partner

    2019 - 2023

    Led investments in health tech for CRV including Viz.ai (Series B), Wheel (Series A), Power (Seed).

Social Capital LP

2017 - 2018

  • Partner

    2017 - 2018

    Board of directors: Propeller Health, Simplee, Glooko

Collective Health

2014 - 2017

  • Chief Commercial Officer

    2014 - 2017

    Joined pre-Series A and scaled through Series D. Led the go-to-market: built and led Sales, Client Success, and BD functions.

Castlight Health

2010 - 2014

  • Business Development, Finance & IR

    2010 - 2014

    Joined Castlight pre-Series A and scaled through IPO. Head of Finance and IR through Castlight's IPO in 2014, Director of Business Development 2010 - 2013.

Life Science Angels

2008 - 2010

  • Health IT Investment Committee

    2008 - 2010

Onyx Pharmaceuticals

2009 - 2009

  • Strategic Planning

    2009 - 2009

Genentech

2009 - 2009

  • Market Planning, BioOncology

    2009 - 2009

Goldman Sachs

2005 - 2008

  • Investment Banking, Healthcare Group

    2005 - 2008

    Executed M&A and financing transactions for biotech, medical device, healthcare technology and life sciences companies including Genentech/Roche, Anormed/Genzyme, Illumina, athenahealth, Amgen.